Drug Combination Details
General Information of the Combination (ID: C28724) | |||||
---|---|---|---|---|---|
Name | Gossypol NP Info | + | 5-fluorouracil Drug Info | ||
Structure | + | ||||
Disease |
Colorectal cancer
[ICD-11: 2B91]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Up-regulation | Cleavage | CASP3 | Molecule Info |
Pathway MAP
|
|
Down-regulation | Expression | CCND1 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Phosphorylation | mTOR | Molecule Info |
Pathway MAP
|
||
Up-regulation | Cleavage | PARP1 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Phosphorylation | S6K1 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | TYMS | Molecule Info |
Pathway MAP
|
||
In-vitro Model | HT-29 | CVCL_0320 | Colon adenocarcinoma | Homo sapiens | ||
HCT 116 | CVCL_0291 | Colon carcinoma | Homo sapiens | |||
RKO | CVCL_0504 | Colon carcinoma | Homo sapiens | |||
Experimental
Result(s) |
Gossypol sensitizes the antitumor activity of 5 FU through down regulation of thymidylate synthase in human colon carcinoma cells. | |||||
Augmenting Drug Sensitivity | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Up-regulation | Cleavage | CASP3 | Molecule Info |
Pathway MAP
|
|
Up-regulation | Cleavage | PARP1 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | TYMS | Molecule Info |
Pathway MAP
|
||
In-vitro Model | HT-29 | CVCL_0320 | Colon adenocarcinoma | Homo sapiens | ||
HCT 116 | CVCL_0291 | Colon carcinoma | Homo sapiens | |||
RKO | CVCL_0504 | Colon carcinoma | Homo sapiens | |||
Experimental
Result(s) |
Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells. |